Chronic lymphocyte leukemia is the most common subtype of leukemia in the United States.  It is presently an incurable disease. Unlike most other types of cancer in which early diagnosis increases the probability that a patient can be cured, treatment with cytotoxic chemotherapy is associated with increased toxicity but no increase in patient survival.

Despite this grim fact, there is good news. A study published in the Journal of Clinical Oncology has shown patients with chronic lymphocyte leukemia in a phase one study, had a reduction of their lymphocyte in 33 % of participant. By doing so, the team of cancer researchers from the State University of New Jersey, established a positive link between green tea and a potential treatment of leukemia.

Several epidemiological studies have demonstrated that the consumption of green tea decreased the risk of cancer. Furthermore, prevention of the apparition of a tumor in animal models by  tea, supported its ability to interfere with basic cancer processes, like angiogenesis and inflammation.

Green tea in a pill is still a long way off before the Food and Drug Administration approves this to be prescribed by your oncologist. By counting the phase 2 and the phase 3 studies, we are talking about 4 to 5 years before commercialization if all went well. And I am not bring the cost of these pills.

A tasty drink made with inexpensive ingredient, tea bought from the local market could sidestep many of these concerns. After all, food is the one medicine that we seem quite willing to take at least three times a day.

Want to find more about green tea go to functional food green tea.